Dr. Abbey’s Research Published in Ophthalmology Retina, a Journal of the American Academy of Ophthalmology
Texas Retina Associates’ Ashkan Abbey, MD, has published research on macular holes in the January 4, 2021, issue of Ophthalmology Retina. Titled “Spontaneous Conversion of Lamellar Macular Holes to Full-Thickness Macular Holes:
read moreTexas Retina Associates Announces the Retirement of Dwain G. Fuller, MD
It is bittersweet that we announce the retirement of Dwain Fuller, M.D., from our practice effective December 31, 2020. He has been an integral part of Texas Retina Associates, caring for patients
read moreDr. Choi Case Report of Rare Retina Condition Published in Journal of VitreoRetinal Disease
Rene Y. Choi, MD, PhD, published a case report titled “Multiple Evanescent White Dot Syndrome Presenting in a Patient with Punctate Inner Choroidopathy” in the November 3, 2020, issue of the Journal
read moreAshkan M. Abbey, MD, Taught a Course at the American Academy of Ophthalmology 2020 Virtual Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, taught a course on “Secondary IOL Techniques for Retinal Specialists” at this year’s AAO 2020 virtual meeting held November 14-17, 2020. With more than 32,000
read moreDr. Choi’s Research on Utilizing Artificial Intelligence to Aid in the Diagnosis of Plus Disease in Retinopathy of Prematurity Patients Published in Ophthalmology Retina
Texas Retina Associates’ Rene Y. Choi, MD, published an article titled “Variability in Plus Disease Identified Using a Deep Learning-Based Retinopathy of Prematurity Severity Scale” in the latest issue of Ophthalmology Retina,
read moreDr. Abbey’s Research Published in Retina, the Journal of Retinal and Vitreous Diseases
Texas Retina Associates’ Ashkan Abbey, MD, has published research in the medical journal Retina. Titled “Refractive Outcomes After Sutureless Intrascleral Fixation of Intraocular Lens with Pars Plana Vitrectomy,” the results of his work
read moreTexas Retina Associates Participating in New Phase II Clinical Trial for Choroidal Melanoma
Texas Retina Associates is pleased to announce its participation in a groundbreaking new Phase II clinical trial for the treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences, we are investigating
read moreWelcome Rene Y. Choi, MD, PhD
Texas Retina Associates welcomes board-certified ophthalmologist and retina specialist Rene Y. Choi, MD, PhD, to our practice on September 1, 2020. Serving patients in our Dallas Main, Denton, Rockwall and Fort Worth
read moreAshkan M. Abbey, MD, Presented at the American Society of Retina Specialists 2020 Virtual Annual Meeting
This past weekend, Texas Retina Associates’ Ashkan M. Abbey, MD, presented at the 38th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS), the largest retinal organization in the world
read moreNorth Dallas Office Moving to a New Suite
To better serve our patients, Texas Retina Associates will be moving our Dallas North office to a much larger suite within the same building. Opening Monday, July 6, 2020, the new Dallas
read more